Clinical Trial Update: Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 study update reporting pharmacokinetics of intraperitoneal meropenem and aztreonam via cycler-therapy in automated peritoneal dialysis patients withou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Peritoneal Dialysis
• Peritoneal Dialysis-associated Peritonitis

Drugs mentioned

• Aztreonam (aztreonam)
• Meropenem (Meropenem)

Snippet

Sponsor: Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | Conditions: Peritoneal Dialysis Associated Peritonitis, Peritoneal Dialysis (PD) | Phase 2, Phase 3 | Status: COMPLETED